Literature DB >> 9009201

Stat5a is mandatory for adult mammary gland development and lactogenesis.

X Liu1, G W Robinson, K U Wagner, L Garrett, A Wynshaw-Boris, L Hennighausen.   

Abstract

Prolactin (PRL) induces mammary gland development (defined as mammopoiesis) and lactogenesis. Binding of PRL to its receptor leads to the phosphorylation and activation of STAT (signal transducers and activators of transcription) proteins, which in turn promote the expression of specific genes. The activity pattern of two STAT proteins, Stat5a and Stat5b, in mammary tissue during pregnancy suggests an active role for these transcription factors in epithelial cell differentiation and milk protein gene expression. To investigate the function of Stat5a in mammopoiesis and lactogenesis we disrupted this gene in mice by gene targeting. Stat5a-deficient mice developed normally and were indistinguishable from hemizygous and wild-type littermates in size, weight, and fertility. However, mammary lobuloalveolar outgrowth during pregnancy was curtailed, and females failed to lactate after parturition because of a failure of terminal differentiation. Although Stat5b has a 96% similarity with Stat5a and a superimposable expression pattern during mammary gland development it failed to counterbalance for the absence of Stat5a. These results document that Stat5a is the principal and an obligate mediator of mammopoietic and lactogenic signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009201     DOI: 10.1101/gad.11.2.179

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  336 in total

1.  Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3.

Authors:  R S Chapman; P C Lourenco; E Tonner; D J Flint; S Selbert; K Takeda; S Akira; A R Clarke; C J Watson
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

2.  Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.

Authors:  R Wen; D Wang; C McKay; K D Bunting; J C Marine; E F Vanin; G P Zambetti; S J Korsmeyer; J N Ihle; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.

Authors:  D Wang; R Moriggl; D Stravopodis; N Carpino; J C Marine; S Teglund; J Feng; J N Ihle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 4.  Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies.

Authors:  J L Vilotte; P L'Huillier; J C Mercier
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

Review 5.  Transcription factor activities and gene expression during mouse mammary gland involution.

Authors:  A Marti; H Lazar; P Ritter; R Jaggi
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 6.  NF-kappaB and apoptosis in mammary epithelial cells.

Authors:  R W Clarkson; C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 7.  Jaks and stats as therapeutic targets.

Authors:  J J O'Shea; R Visconti; T P Cheng; M Gadina
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

8.  Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.

Authors:  S Mori; S I Nishikawa; Y Yokota
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 9.  Developing a mammary gland is a stat affair.

Authors:  L Hennighausen; G W Robinson; K U Wagner; X Liu
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

10.  Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.

Authors:  H Nishio; K Matsui; H Tsuji; A Tamura; K Suzuki
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.